Novalead Pharma Private Limited - Company Profile

It is a pharma private limited company based in Pune, Maharashtra, India, established in 2007.
2007 Pune, Maharashtra, India Active
Last Updated:
About Novalead Pharma Private Limited

Novalead Pharma Private Limited, a active private limited company, was established on 31 October 2007 in Pune, Maharashtra, India. Engaging in pharma contract r&d within the information and communication sector, it holds CIN: U73100PN2007PTC130929. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹3.74 Cr and a paid-up capital of ₹0.18 M.

It upholds a compliant status. Its leadership includes Sankara Narayanan Sankarasubramanian (Nominee Director), Sudhir Kulkarni Appaji (Director), Vandan Girdharlal Agrawal (Nominee Director). Past directors included Sankara Narayanan Sankarasubramanian, Homi Rustam Khusrokhan, Mohamed Iqbal Dharamsi. It holds no open charges and ₹3.34 Cr settled loans. Its latest AGM occurred on 24 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No-05, Third Floor, Ram Indu Park, Survey No-131/1B/2/11, Baner Taluka Have, Li,, Pune, Maharashtra, 411045.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U73100PN2007PTC130929

  • Registration Number

    130929

  • Incorporation Date

    31 October 2007

  • Authorized Capital

    ₹3.74 Cr

  • Paid-Up Capital

    ₹0.18 M

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.74 Cr
  • Paid Up Capital ₹ 0.18 M
  • Company Age 18 Year, 3 Months
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 3.34 Cr
  • Revenue Growth **** 513.86%
  • Profit Growth **** 353.23%
  • Ebitda **** 53.09%
  • Net Worth 17.90%
  • Total Assets **** 18.52%
Company report

Novalead Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Novalead Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Novalead Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sankara Narayanan Sankarasubramanian Nominee Director 24 Nov 2022 Current
Sudhir Kulkarni Appaji Director 17 Aug 2009 Current
Vandan Girdharlal Agrawal Nominee Director 24 Nov 2022 Current
Atul Sharad Aslekar Director 31 Oct 2007 Current
Supreet Deshpande Kiran Director 31 Oct 2007 Current
Girish Vithalrao Lakhe Director 17 Aug 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Alternate Director 23 Mar 2021 Past
Pramod Abcsdd Director 15 Sep 2021 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Nominee Director 29 Sep 2021 Past
Pramod Abcsdd Additional Director 29 Sep 2009 Past
Pramod Abcsdd Nominee Director 25 Mar 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Novalead Pharma.

Novalead Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 513.86% increase. The company also saw a substantial improvement in profitability, with a 353.23% increase in profit. The company's net worth Soared by an impressive increase of 17.9%.

Novalead Pharma revenue growth over time
Novalead Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
513.86%
*******
*******
*******
*******
Revenue from Operations
*******
904.25%
*******
*******
*******
*******
Total Assets
*******
18.52%
*******
*******
*******
*******
Profit or Loss
*******
353.23%
*******
*******
*******
*******
Net Worth
*******
17.90%
*******
*******
*******
*******
EBITDA
*******
53.09%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Novalead Pharma?

In 2023, Novalead Pharma had a promoter holding of 42.79% and a public holding of 57.21%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹0

Satisfied Charges

₹33,380,000.00

Charges Breakdown by Lending Institutions
  • Biotechnology Industry Research Assistance Council : 3.34 Cr
Latest Charge Details
Date Lender Amount Status
03 Jan 2011 Biotechnology Industry Research Assistance Council ₹3.34 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Novalead Pharma?

Unlock and access historical data on people associated with Novalead Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Novalead Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novalead Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Novalead Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Novalead Pharma Private Limited last Annual general meeting of members was held on 24 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Novalead Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.

  • Charges

    The activity A charge registered on 03 Jan 2011 via Charge ID 10267794 with Biotechnology Industry Research Assistance Council was fully satisfied on 21 Mar 2024. was completed.

  • Director Appointment

    Sankara Narayanan Sankarasubramanian was appointed as a Nominee Director was appointed as a Nominee Director on 24 Nov 2022 & has been associated with this company since 3 years 2 months . was recorded as a recent event.

  • Director Appointment

    The activity Vandan Girdharlal Agrawal was appointed as a Nominee Director was appointed as a Nominee Director on 24 Nov 2022 & has been associated with this company since 3 years 2 months . was completed.

  • Charges

    Progress on A charge with Biotechnology Industry Research Assistance Council of Rs. 3.34 Cr registered on 03 Jan 2011 with Charge ID 10267794 was modified on 23 Sep 2015. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Novalead Pharma Private Limited?

The CIN of Novalead Pharma Private Limited is U73100PN2007PTC130929.

Where is Novalead Pharma Private Limited headquartered?

Novalead Pharma Private Limited is headquartered at Plot No-05, Third Floor, Ram Indu Park, Survey No-131/1B/2/11, Baner Taluka Have, Li,, Pune, Maharashtra, 411045.

When was Novalead Pharma Private Limited incorporated?

Novalead Pharma Private Limited was incorporated on 31 October 2007.

Who are the current directors of Novalead Pharma Private Limited?
What is the primary industry of Novalead Pharma Private Limited?

The primary industry of Novalead Pharma Private Limited is Information And Communication.

Is Novalead Pharma Private Limited a listed company?

Novalead Pharma Private Limited is unlisted.

What is the capital structure of Novalead Pharma Private Limited?

The authorized capital of Novalead Pharma Private Limited is ₹3.74 Cr, and the paid-up capital is ₹0.18 M.

What is the compliance status of Novalead Pharma Private Limited?

The compliance status of Novalead Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available